Target intelligence / Profile preview

Arylsulfatase F (ARSF)

Target
ARSF
Molecular classification
Enzyme, Sulfatase family, Arylsulfatase subfamily
01

Overview

Arylsulfatase F is a member of the sulfatase enzyme family, specifically the arylsulfatase subfamily, encoded by the ARSF gene on the X chromosome. It catalyzes the hydrolysis of sulfate esters, exhibiting activity toward substrates such as 4-methylumbelliferyl sulfate. Although similar in function to other arylsulfatases, its precise physiological substrate remains less clearly defined. Mutations in ARSF have been associated with conditions such as Martin-Probst syndrome and potentially autism spectrum disorder, though its disease association is less prominent than other sulfatases like arylsulfatase A. There are no approved therapeutic drugs directly targeting Arylsulfatase F, and the enzyme is not a classic biomarker or drug target in current clinical practice. The frequently conflated Arylsulfatase A (ARSA), a related enzyme, is a well-known target for metachromatic leukodystrophy and lysosomal storage disorders but is genetically and functionally distinct from Arylsulfatase F (ARSF).

Other names
Arylsulfatase FARSFARSF_HUMAN
02

Mechanism of action

Catalysis of sulfate ester bond hydrolysis in specific substrates (general sulfatase mechanism; no approved drugs specifically targeting ARSF identified)

03

Biological functions

Sulfuric ester hydrolase activityArylsulfatase activitySphingolipid metabolismProtein metabolism
04

Disease associations

Martin-Probst syndromeAutism spectrum disorderPotential roles in lysosomal storage diseases (evidence less well established compared to Arylsulfatase A)
05

Safety considerations

No major direct therapeutic safety concerns reported (no drugs targeting ARSF currently); broader sulfatase family deficiencies (not specific to ARSF) can be linked to storage disorders

Beyond the preview

Go deeper on Arylsulfatase F (ARSF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arylsulfatase F (ARSF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call